美国 爱尔康公司 (Alcon Laboratories, Inc.)   
爱尔康公司 (Alcon Laboratories, Inc.) 成立于1947年，是全球最大的眼科药品与医疗器械专业公司。在全球75个国家和地区设有分公司，拥有15,000多名员工，5 个研发中心，14个生产工厂，产品销售遍及180多个国家和地区。爱尔康公司全面研发、生产、营销眼部医药品、眼科手术设备装置、隐形眼镜相关护理产品和其他治疗疾病、调节不适的眼部护理消费品。除了没有开展生产销售眼镜及隐形眼镜产品的业务以外，爱尔康涉足了眼科学产品的所有领域。

爱尔康公司高层管理人员敏锐的洞察力和雀巢公司坚定不移的支持，爱尔康公司一直保持其在眼科市场上的领先地位及在全球范围内飞快的发展速度。2008年销售额已超过了63亿美元，遥居同行业榜首。在未来的5年中，爱尔康计划在研发方面投资30亿美元，公司确信这将是眼科领域最大的科研投资。此外，爱尔康公司在美国《财富》杂志“100个最值得工作的公司”年度调查中连续数年榜上有名。

虽然公司主要关注于提供治疗眼部疾病与不适症状的最佳产品与方案，爱尔康同时还致力于减少全球可预防性失明。在过去的3年里，爱尔康在全球范围内捐赠了1.36亿美元现金与产品用于慈善活动，其中包括低收入患者援助项目以及对1200个医疗任务进行赞助，从而帮助那些没有条件治疗眼部疾病的人恢复视力。爱尔康在72个国家设有医师培训中心，能够提供最新的眼部护理技术持续培训，其中大部分培训中心都设在新兴市场。此外，爱尔康还努力减轻生产对环境所造成的影响，大力开展诸如产品返回与回收、材料声明、生命周期分析及产品监管等项目。

爱尔康（中国）眼科产品有限公司是美国爱尔康公司于1995年在中国设立的独资公司，目前拥有500多名员工和9个办事处，产品销售遍及全国各地，包括新疆，西藏等边远地区。爱尔康（中国）眼科产品有限公司作为爱尔康大家庭的一员，在过去的十几年间，秉承了爱尔康公司的一贯宗旨，为推动中国眼科事业的发展做出了不懈的努力。爱尔康(中国)眼科产品有限公司将牢记对眼科医生和患者的承诺，加强与中国眼科专家的合作，携手共创辉煌的明天。

爱尔康（中国）同中华医学会眼科学分会紧密合作，举办各种规模各种类型的学术研讨会，全国眼科年会，以及国际眼科会议，为国内眼科医生的学术交流活动创造搭建平台，为推动中国眼科事业的发展做出不懈的努力。同时爱尔康（中国）还同中国残联，健康快车等慈善机构的合作，支持各种扶贫项目，为中国的防盲治盲工作贡献力量。
 
Founded in 1945, Alcon Laboratories, Inc. traces its roots back to two pharmacists, Robert Alexander and William Conner, who opened a small pharmacy in Fort Worth, Texas, and combined the first syllables of their last names to create the name Alcon.

Majority owned by Nestlé S.A. and incorporated in Hünenberg, Switzerland with U.S. operations based in Fort Worth, Texas, our team of over 15,000 dedicated employees worldwide develops, manufactures, and distributes hundreds of eye care products in more than 180 countries. This seasoned and diverse group of people, who encircle the globe, are united by a common mission: to make Alcon the most trusted eye care company worldwide and the first choice of eye care professionals and their patients.

In March 2002, Alcon conducted a partial initial public offering (IPO) on the New York Stock Exchange (NYSE). Nestlé still owns approximately 75 percent of the company.

Alcon's core business is centered on three key divisions – Surgical, Pharmaceutical and Consumer Vision Care. As of 2008, sales reached US$6.3 billion.

We conduct our business from Alcon offices located in 75 countries around the world in regions including Canada and the Far East; Europe, Middle East and Africa; Latin America and the Caribbean; and the United States.

People
Although the average tenure of Alcon employees is just nine years, it is not uncommon to find people who have worked for Alcon for 25 years or more. The dedication and commitment is contagious – often when people arrive, they see no reason to leave. Instead, they see several reasons to stay. Alcon employees are constantly being challenged and rewarded for excellence. It's easy to be proud of who we are and what we do. More importantly, it's easy to be proud of how we do it. We don't just enhance, preserve and restore vision; we foster an Alcon family of nearly 15,000, around the world who dedicate themselves to this same mission.

Learn more about the people who make Alcon successful.

Corporate Responsibility
Community & Humanitarian Involvement
We recognize we offer what many people need, whether or not they can afford it or even know it exists. As a result, a significant part of our culture revolves around our responsibility to the community and to humanity as a whole. Many of our charitable endeavors involve services for, and support of, the communities in which we operate and live. We also offer a patient assistance program to assist those in need of our therapies but who lack the resources to pay for them.

In 2008 our Medical Missions Program donated US$55 million in cash and products to charitable activities, including patient access assistance programs for low income patients and 1,200 medical missions in more than 90 countries that restore vision to those without access to eye care services. As part of these missions, we partner with physicians and humanitarian organizations such as the ORBIS "Saving Sight Worldwide" Program and Mercy Ships. Additionally, we established The Alcon Foundation, Inc. to support the philanthropic interests of Alcon that include research efforts and organizations in the field of eye care with special consideration given to those programs that advance the education and skill levels of eye care professionals. The Foundation also supports leadership programs, education and the arts in the communities in which we operate.

Learn more about Alcon's involvement in the community and with humanitarian organizations around the world.

Commitment to Quality
We consider quality to be much more than simple conformance to product or program specifications and requirements. We seek to continually improve all aspects of our business processes and quality management systems. We strive to comply with the highest level of regulatory and statutory requirements, and we consistently meet or exceed these standards in each market. And we recognize that the global market can be a complicated one with local controls and requirements. As a global company, we are diligent in ensuring compliance in each of our global markets.

Learn more about Alcon's commitment to quality.

Research & Development
Alcon's R&D organization is the largest of its kind in the world consisting of more than 1,350 employees, including approximately 300 individuals who are M.D.s, O.D.s or Ph.D.s. Our researchers, scientists and engineers work in one of five state-of-the-art research facilities in the U.S., Spain and Switzerland and partner with leading academic institutions, other healthcare companies and individual physicians to ensure that our products are among the best in eye health.

Learn more about Alcon's research and development efforts.

Business Focus
Alcon's core business is centered on three key divisions – Surgical, Pharmaceutical and Consumer Vision Care.

Surgical
Alcon offers the industry's most comprehensive portfolio of ophthalmic surgical products, enabling surgeons to achieve optimal results for their patients. As the worldwide leader in ophthalmic surgical products, Alcon occupies the premier position in surgical suites across the globe and manufactures and markets products for all ocular surgical procedures. As the developer and manufacturer of the worlds' most preferred line of intraocular lenses, AcrySof®, which is implanted globally in 60 percent of all cataract patients, Alcon is redefining vision for